Skip to content
AwardedBelgiumGoods€1,086,000

177 Lu-PSMA

Published
Published 17 July 2025

Overview

Le présent marché porte sur la fourniture de produit radiopharmaceutique à usage thérapeutique et plus précisément le Lutecium-177 (177Lu) – PSMA pour les services de Médecine Nucléaire d’HUmani sc..

Key details

Country
Belgium
Status
Awarded
Category
Goods
Estimated value
€1,086,000
Procedure
Direct
Published
17 July 2025
Classification (CPV)
Radio-isotopesTechnetiumIsotopic reagents

Award outcome

Awarded value
€1,085,377
Award date
6 May 2025
Contract period
— → 18 August 2028
Winner
  • NOVARTIS PHARMA

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    17 July 2025

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: 177 Lu-PSMA — won by NOVARTIS PHARMA — Skim